Inventory of Supplemental Information
1. Figure (GPCRs, enzymes, membrane proteins, etc.) . For each gene four independent siRNAs targeting each gene were used. First the reporter assay was optimized using known TGF-β/Smad signaling mediators, including TGF-β type I receptor/ALK5 and Smad3. The screen identified known signaling components, including TGF-β receptors and Smad3 as regulators. Among the candidate genes not previously identified to play a role in TGF-β signaling the E3 ubiquitin ligase RNF12 was selected as it scored positive for multiple independent siRNAs and this hit was among the most potent regulators. For some of the other regulators that were identified not always independent siRNAs scored positive, indicating possible off target effects. In addition, top list of putative regulators were further challenged by additional siRNAs and also further validated by shRNA-mediated depletion, rescue experiments with cDNAs that are not targeted by shRNA and overexpression studies. Only few targets remained positive after this thorough testing (differences may also prevail between different cell types, and further testing is needed for many targets). experiments. An unresponsive control region of the same gene that showed no response was used as a control (For control region of Smad7 promoter, data not shown). The full coding sequence of zebrafish Rnf12 was amplified from cDNAs derived from 24 h postfertilization (hpf) embryos with an upper primer (zp1U: 5'-GTGGGTACCATGGAGGGTCAGGATAATGC-3') and a lower primer (zp1D: 5'-GCCGACTAGTCATGACAACACTCTCACGG-3'). The zRnf12 cDNA sequence was deposited in GenBank with accession number XM_680935.4. The sequence was then subcloned into pXT7 and pBKS to generate vectors for synthesizing mRNA and antisense RNA probes in vitro, respectively. The zRnf12 deletion and mutations were generated by PCR amplification of zRnf12 with the appropriate primers. These were subcloned into pXT7 or pCMV-Myc vectors. All PCR products were confirmed by sequence alignments. The primer sequences were listed in the supplementary material and method (see Primers and Antibodies).
(2) Generation of Rnf12 BAC targeting construct
To generate Rnf12 BAC targeting construct, targeting arms were PCR amplified using primers 5'-GCCTTCGAACATCTCTGAGC-3', 5'-GAGCCGGACTAATCCAAACA-3', cloned into pCR-BluntIITOPO (Invitrogen), and linearized with NheI to introduce an Ampicilin-Puromycin cassette from pBluescript. The targeting cassette was inserted in a Cast/Ei Rnf12 BAC RP26-81P4 by homologous recombination in bacteria, and the resulting construct was used to target specifically the Cast/Ei X chromosome of the Rnf12 +/-ES cell line. Colonies were selected under Neomycin and Puromycin selection, and the absence of Rnf12 expression was confirmed by Western analysis.
(3) Immunoprecipitation, immunoblotting and biotinylation
Cells were lysed with 1 ml of lysis buffer (20 mM Tris-HCl, pH 7.4, 2 mM EDTA, 25 mM NaF, 1% Triton X-100) plus protease inhibitors (Sigma) for 10 min at 4°C. After centrifugation at 12,000 ×g for 15 min, the protein concentration was measured and equal amounts of lysate were used in immunoprecipitations with different antibodies and protein A-Sepharose (GE Healthcare Bio-Sciences AB) for 3 h at 4°C. Thereafter, the precipitants were washed three times with washing buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS) and the immune complexes were eluted with sample buffer containing 1% SDS for 5 min at were untreated or treated with TGF-β3 (5 ng/ml), activin A (50 ng/ml) or BMP6 (50 ng/ml) overnight. CAGA 12 -Luc was used as Smad3-Smad4 driven transcriptional reporter (Dennler et al., 1998) . Harvested cells were assayed for luciferase activity with a Perkin Elmer luminometer. The internal control, β-gal (30 ng) expression plasmid, was used to normalize transfection efficiency. Each experiment was performed in triplicate and data represent the mean ± SD of three independent experiments after normalization to β-gal activity.
(6) Immunofluorescence
For EMT assay, HaCaT cells with stable depletion of RNF12, over-expression of RNF12, or controls were plated onto collagen-I coated coverslips. After adhesion, cells were serum-starved overnight and then incubated with or without TGF-β3 for 36 h in 1% FBS.
Next, cells were fixed for 10 min in 4% paraformaldehyde in phosphate buffered saline (PBS), permeabilized with 0.2% TritonX100-PBS, and then blocked with 3% bovine serum albumin (BSA) in PBS for 30 min at room temperature. Anti-E-cadherin (BD Transduction Laboratories™) was diluted at 1:1000 in 3% BSA-PBS and incubated with the slides for 3 h at room temperature. Secondary AlexaFluor488-labeled anti-mouse antibody (Molecular Probes) was added at a dilution of 1:200 in 3% BSA-PBS, together with Phalloidin (Molecular Probes). These were incubated for 1 h at room temperature.
Coverslips were mounted with DAPI-containing VECTASHIELD mounting medium (Vector Laboratories, Inc.). Fluorescence images were acquired with a Zeiss Axioplan microscope.
For RNF12 and Smad7 colocalization, mES cells were pretreated with MG132 (10 µM) for 5 h to inhibit proteasome, and then processed as described above with primary anti-Smad7 (sc-7004) and anti-RNF12 (ab57230) antibodies and secondary AlexaFluor593-labeled anti-goat and AlexaFluor488-labeled anti-mouse antibodies (Molecular Probes).
(7) Lentiviral transduction
Lentiviruses were produced by transfecting pLKO-1 (for the shRNA-knockdown) or pLV-bc-CMV (for cDNA expression) plasmids together with helper plasmids pCMV-VSVG, pMDLg-RRE (gag/pol), and pRSV-REV into HEK293T cells. Cell supernatants were harvested 48 h after transfection and were either used to infect cells or stored at -80 °C.
To obtain stable cell lines, cells were infected at low confluence (20%) for 24 h with lentiviral supernatants diluted 1:1 with normal culture medium in the presence of 5 ng/ml of polybrene (Sigma). 48 h after infection, cells were placed under puromycin selection for one week, and then passaged before use. Puromycin was used at 1 µg/ml to maintain HaCaT, HeLa, Hep3B, HepG2 and mES stable cells. Lentiviral shRNAs were obtained from Sigma (MISSION® shRNA). Typically, 5 shRNAs were identified, tested, and the most effective one or two shRNAs were used for the experiment. We used TRCN0000004139 (#1) and TRCN0000004142 (#2) for human RNF12 knockdown, TRCN0000095739 (#1) and TRCN0000095742 (#2) for mouse Rnf12 knockdown. Cys. After two washes, cells were chased in medium supplemented with cold (unlabeled) Met and Cys (100 μg/ml) before harvesting. Endogenous Smad7 was collected from extracts by immunoprecipitation, resolved by SDS-PAGE and visualized by autoradiography. Each experiment was performed twice in duplicate.
(9) BrdU Analysis
Control and RNF12-depleted cells were plated onto collagen I-coated coverslips. After adhesion, cells were untreated or treated for 16 h with cytokines (activin A or TGF-β3), as indicated in the text and figure legends. For BrdU incorporation, cells were incubated for 2 h with 10 µM BrdU (Roche), and processed according to a standard BrdU labeling protocol (Sasaki et al., 1989) . Cells were counterstained with Hoechst for counting, and then scored for BrdU staining. Experiments were performed at least twice, each time in triplicate, with not less than 1500 cells per sample.
(10) Chromatin Immunoprecipitation
HaCaT cells grown to 100% confluence were treated for 2 h with or without TGF-β3 (1 ng/ml for cells with RNF12 over-expression and 5 ng/ml for cells with RNF12 knockdown). mES cells grown to 80% confluence were treated for 1 h with or without BMP2 (50 ng/ml). Next, HaCaT cells were crosslinked with 1% formaldehyde for 15 min at 37°C; mES cells were cross-linked with 1.6 mM disuccinimidyl glutarate (Sigma) in PBS for 45 min at room temperature, followed by crosslinking with 1% formaldehyde for 15 min at room temperature. Crosslinking reactions were quenched with 0.125 M glycine for 5 min at room temperature. Cells were rinsed twice with PBS and harvested with a silicon scraper. Cells were resuspended, lysed (1% SDS, 50 mM Tris-HCl; pH 8.0, 5 mM EDTA, protease inhibitors), and sonicated to obtain DNA fragments of approximately 300-500 bp long, on average. Samples were then centrifuged at 14 x 10P 3 P rpm for 10 min.
The supernatant was diluted (20 mM Tris, pH 8.0, 2 mM EDTA, 1% Trion X-100, 150 mM NaCl, and protease inhibitors) and pre-absorbed with 50 μl of protein A beads (Zymed). Supernatants were then incubated with 10 μg antibodies (as indicated) overnight at 4°C. The immunocomplexes were collected with 100 μl of protein A beads in a 3 h co-incubation. Then, the mixture was washed sequentially with TSE I (0.1% SDS, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 1% Triton X-100, 150 mM NaCl, and protease inhibitors), TSE II (0.1% SDS, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 1% Triton X-100, 500 mM NaCl, and protease inhibitors), LiCl buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.25 mM LiCl, 0.1% NP-40, and 1% deoxycholate sodium), and TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0). The bound immunocomplex was eluted by incubating with 400 μl of fresh elution buffer (25 mM Tris-HCl pH 8.0, 10 mM EDTA, 0.5% SDS) at 65°C for 15 min with occasional vortexing. The crosslinking was reversed in an overnight incubation at 65°C. Whole cell extract (WCE) DNA (fraction reserved from the sonication step) was also subjected to crosslinking reversal.
Immunoprecipitated DNA and WCE DNA were then purified by treating with RNaseA, proteinase K, and multiple phenol:chloroform:isoamyl alcohol extractions.
Immunoprecipitated DNA was analyzed with absolute qRT-PCR and the amplification product was expressed as a percentage of the input (WCE) for each condition. The primers used to amplify the Smad-binding regions of the indicated gene promoters were: mId1 promoter, forward 5'-CGTCCGGGTTTTATGAATGG-3' and reverse 5'-AGCGGCTCAGACCGTTAGAC-3', as previously described (Korchynskyi and ten Dijke, 2002) ; Smad7 promoter, forward 5'-ATCTGTTGTTTGCGAAACA-3' and reverse 5'-GGCCCTCCGCTCGGCTGGTT-3', as previously described (Nagarajan et al., 1999) ; and PAI-1 promoter, forward 5'-GCAGGACATCCGGGAGAGA -3' and reverse 5'-CCTGAGAACCTCCCTTGACCTT -3', as previously described (Dennler et al., 1998) . Primers for the control region for each gene promoter are available upon request.
(11) Zebrafish embryo assay
Total RNA was isolated from embryos at different stages using Trizol reagent (TAKARA). The first strand cDNAs synthesized from total RNAs were used as templates, according to the SuperScript Kit (Invitrogen) instructions. qRT-PCR reactions were performed for 30 cycles and a final extension for 6 min with the β-actin internal control. The primer sequences were listed in supplementary material and method (primers and antibodies).
Capped mRNAs were synthesized with T7 Cap Scribe (Roche), according to the manufacturer's instructions. For preparation of digoxigenin-labeled antisense probes, plasmids that contained the zRnf12 cDNAs were linearized with KpnI. Linearized template DNA was transcribed in vitro with T7 polymerase and digoxigenin-UTP (Roche). In situ hybridizations were performed as previously described (Prince et al., 1998) .
To knockdown zRnf12 gene function, we used two morpholino oligonucleotides synthesized by Gene Tools (zrnf12-MO1: 5'-CATTATCCTGACCCTCCATCACTGT- His6-Smad7 and GST-RNF12 expression constructs were generated by sub-cloning into pET28a and pGEX-4T1 vectors. His6-Smad7 and GST-RNF12 plasmids were used to transform the E.coli strain BL21 or Rosetta, respectively. Cultures were grown overnight at 37 °C. The next day, cultures were diluted 1:50 in fresh LB medium and grown at 37 °C to an OD600 of 0.6. Cells were then induced overnight at 24 °C in the presence of 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG), 20 mM Hepes pH 7.5, 1 mM MgCl2 and 0.05 % Glucose.
For His6-Smad7 purification, the washed cell pellet was resuspended in lysis buffer (50 mM HEPES-KOH, pH 7.6, 500 mM NaCl, 25 mM MgCl2, 20% glycerol, 0.1% NP-40, complete EDTA free protease inhibitors (Roche), 1 mM PMSF). After sonication and a freeze-thaw step, the supernatant of the cell lysate was incubated with Talon beads (BD Biosciences) in the presence of 20 mM imidazole. Beads were washed four times with lysis buffer lacking imidazole. Purified proteins were eluted in lysis buffer containing 200 mM imidazole.
For GST-RNF12 purification, the washed pellets were resuspended in lysis buffer (PBS, 0.5 M NaCl, complete protease inhibitors (Roche), 1 mM PMSF, 1% Triton X-100).
After sonication and a freeze-thaw step, the supernatant of the cell lysates were incubated with Glutathione sepharose (GE Healthcare). Beads were washed twice with lysis buffer and three times with 50 mM Tris pH 7.5, 0.5 M NaCl. Purified proteins were eluted in 50 mM Tris pH 7.5, 0.5 M NaCl and 20 mM Glutathione.
(13) In vitro Ubiquitilation assay
Smad7 protein and RNF12 protein are generated in E.coli as His-tagged and GST fusion protein, respectively. In vitro ubiquitin assays were carried out by incubating Ubiquitin activating enzyme E1 (Ube1 40nM), Ubiquitin (8 µM), UbcH6 (0.7 µM), 1 µg HisSmad7 and 300 ng GST-RNF12 fl or CA mutant at 37 °C for 3 h in reaction buffer, 50 mM Tris-HCL (pH 7.5), 5 mM MgCl2, 1mM DTT, 2mM ATP with proteases inhibitor. 9 µl of the 10 µl reaction system were diluted with RIPA buffer and followed with antiSmad7 immunoprecipitation and anti-Ubiquitin (or anti-Smad7) immunoblottings. 1 µl of the 10 µl reaction system were loading as input control. 
